Mizuho reissued their hold rating on shares of National Health Investors, Inc. (NYSE:NHI) in a research report report published on Wednesday, October 4th. They currently have a $82.00 price target on the real estate investment trust’s stock.
Other equities analysts have also issued reports about the company. Zacks Investment Research upgraded National Health Investors from a hold rating to a buy rating and set a $90.00 price target on the stock in a research note on Tuesday, September 5th. BidaskClub lowered National Health Investors from a hold rating to a sell rating in a research note on Wednesday, August 9th. Stifel Nicolaus restated a buy rating and set a $82.00 price target on shares of National Health Investors in a research note on Wednesday, October 4th. Finally, ValuEngine lowered National Health Investors from a buy rating to a hold rating in a research note on Tuesday, June 13th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company’s stock. National Health Investors currently has an average rating of Hold and an average target price of $80.17.
National Health Investors (NYSE NHI) opened at 77.49 on Wednesday. The stock has a 50 day moving average price of $78.75 and a 200 day moving average price of $76.90. The stock has a market cap of $3.18 billion, a PE ratio of 19.90 and a beta of 0.56. National Health Investors has a 52 week low of $66.31 and a 52 week high of $81.21.
National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The business had revenue of $69.84 million during the quarter, compared to the consensus estimate of $67.68 million. During the same quarter in the previous year, the firm posted $1.22 earnings per share. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, equities analysts predict that National Health Investors will post $3.86 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “Mizuho Reaffirms Hold Rating for National Health Investors, Inc. (NYSE:NHI)” was originally reported by BBNS and is owned by of BBNS. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://baseballnewssource.com/markets/mizuho-reiterates-hold-rating-for-national-health-investors-inc-nhi/1698000.html.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a yield of 4.90%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s payout ratio is 97.69%.
In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total value of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.19% of the stock is currently owned by insiders.
Several institutional investors and hedge funds have recently made changes to their positions in NHI. BlackRock Inc. boosted its holdings in shares of National Health Investors by 6,473.4% in the 1st quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock worth $241,753,000 after acquiring an additional 3,277,930 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of National Health Investors by 3.3% in the 1st quarter. Vanguard Group Inc. now owns 6,219,436 shares of the real estate investment trust’s stock worth $451,717,000 after acquiring an additional 201,133 shares in the last quarter. Nuveen Asset Management LLC acquired a new position in shares of National Health Investors in the 1st quarter worth approximately $11,559,000. MARSHALL WACE ASIA Ltd acquired a new position in shares of National Health Investors in the 1st quarter worth approximately $6,794,000. Finally, Marshall Wace North America L.P. acquired a new position in shares of National Health Investors in the 1st quarter worth approximately $6,794,000. 70.11% of the stock is currently owned by institutional investors and hedge funds.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with our FREE daily email newsletter.